Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Servier
Servier
Pfizer
Hoffmann-La Roche
Hoffmann-La Roche
Neonc Technologies, Inc.
Adela, Inc
Apollomics Inc.
Tempus AI
Taproot Health
VitaMed Research LLC
Hoffmann-La Roche
Shanghai Yunying Medical Technology
P-Cure
Quadriga Biosciences, Inc.
SpeciCare
Celgene
IGF Oncology, LLC
INSYS Therapeutics Inc